9-color and 10-color flow cytometry in the clinical laboratory.
about
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocolsAdvances in complex multiparameter flow cytometry technology: Applications in stem cell research.Development-associated immunophenotypes reveal the heterogeneous and individualized early responses of adult B-acute lymphoblastic leukemia.Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells.STAT3-activated GM-CSFRα translocates to the nucleus and protects CLL cells from apoptosis.Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing.Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.Enumeration of circulating fibrocytes for clinical use in asthma by an optimized single-platform flow cytometry assay.Nucleosides accelerate inflammatory osteolysis, acting as distinct innate immune activators.Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission.Central nervous system involvement in acute myeloid leukemia patients undergoing hematopoietic cell transplantation.Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation.Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemiaMinimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic SyndromeDetection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH.How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet.PhenoGraph and viSNE Facilitate the Identification of Abnormal T-Cell Populations in Routine Clinical Flow Cytometric Data.Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia.Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients.Detection of non-CLL-like monoclonal B cell lymphocytosis increases dramatically in the very elderly, while detection of CLL-like populations varies by race: findings in a multiethnic population-based cohort of elderly women.Detection of minimal residual disease in B lymphoblastic leukemia using viSNE.Evaluation of allogeneic transplantation in first or later minimal residual disease - negative remission following adult-inspired therapy for acute lymphoblastic leukemia.Novel flow cytometry approach to identify bronchial epithelial cells from healthy human airways.
P2860
Q24604720-982751EB-1B91-431F-BF9E-70AF92872376Q30479710-61918D4B-9444-43FE-8A42-E7777F5F5ECCQ33590468-06F5B096-9B41-454F-A892-1DFE823E4F1CQ33952249-058622B9-7FC1-4521-92B7-1C53B0BC588DQ34177799-2CA4B911-2377-4011-BAB1-3D649777A6A4Q34364350-7C11F9CE-C790-43A8-88F4-4125B0296D7AQ34877613-A0DFFD6C-889C-481A-8E4F-014B2CA5EF0EQ35870325-09CB8F15-326C-418F-80F6-F074F968AD3BQ36257329-CD1B8A53-7F30-4CC0-896C-2FC6F778C4F9Q36467544-6FBC2B0B-2D7C-4967-AFC0-569FCE055544Q36483114-C2A835EE-B901-4DFA-915B-86915A3E78E1Q36505822-BB0138AF-BD5A-4137-8709-8A7217BD7FE5Q37148110-42A7FA43-1F81-44BA-9A62-7989C089CB56Q37207443-EADBF829-2550-4E72-BDAB-6811B3CBECB1Q37481981-93FCBECF-AC06-4BA1-87D6-9796A6EE1216Q37545067-556168D6-1F91-4752-8547-0BEBCFDDBA3DQ38596976-2C1B900A-B20B-4F7B-967F-233B68642C0EQ38681322-A260AEB0-027E-40DB-83B0-9EEAB26F1260Q39035188-B3266C79-8BC2-4A86-9D57-C5647CDBB31FQ39549622-67714885-357A-455D-9FE6-DDA4B489D646Q40939448-930076C6-470C-4ADE-870A-0AD105894052Q41009415-6F70F896-61A5-4951-A90D-555560E13477Q42086771-F293F52F-2691-435C-9CB9-27D9D61FBD61
P2860
9-color and 10-color flow cytometry in the clinical laboratory.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
9-color and 10-color flow cytometry in the clinical laboratory.
@ast
9-color and 10-color flow cytometry in the clinical laboratory.
@en
type
label
9-color and 10-color flow cytometry in the clinical laboratory.
@ast
9-color and 10-color flow cytometry in the clinical laboratory.
@en
prefLabel
9-color and 10-color flow cytometry in the clinical laboratory.
@ast
9-color and 10-color flow cytometry in the clinical laboratory.
@en
P1476
9-color and 10-color flow cytometry in the clinical laboratory.
@en
P2093
Brent Wood
P304
P356
10.1043/1543-2165(2006)130[680:CACFCI]2.0.CO;2
P577
2006-05-01T00:00:00Z